By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LivaNova PLC 

20 Eastbourne Terrace

London    W2 6LG  United Kingdom
Phone: 281-228-7262 Fax: n/a


SEARCH JOBS

LivaNova PLC, headquartered in London, UK, is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. The company employs approximately 4,600 employees worldwide. With a presence in more than 100 countries, LivaNova operates as three business franchises: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.A.), respectively.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Damien McDonald

CFO: Vivid Sehgal

JOBS:

Please click here for LivaNova job opportunities.


Key Statistics


Email: Investor.Relations@LivaNova.com
Ownership: Public

Web Site: LivaNova
Employees:
Symbol: LIVN
 



Industry
Medical Device






Company News
LivaNova (LIVN) Reports Second Quarter 2017 Results 8/10/2017 6:35:09 AM
LivaNova (LIVN)’s Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-On Payment From The Center For Medicare And Medicaid Services 8/7/2017 6:56:39 AM
LivaNova (LIVN) Release: VNS Therapy Receives CE Mark For Expanded MRI Labeling 8/1/2017 6:43:59 AM
LivaNova (LIVN) Plant Linked to Heart Surgery Infections From Contaminated Medical Devices 7/14/2017 7:53:53 AM
FDA Green Lights LivaNova (LIVN)'s VNS Therapy for Drug-Resistant Epilepsy in Kids 6/29/2017 10:15:26 AM
LivaNova (LIVN) To Host Conference Call For Second Quarter 2017 Results 6/27/2017 11:31:37 AM
LivaNova (LIVN) Release: VNS Therapy Receives FDA Approval For Expanded MRI Labeling 6/21/2017 8:00:39 AM
LivaNova (LIVN) Appoints Keyna Skeffington As Senior Vice President And General Counsel 6/12/2017 11:27:44 AM
LivaNova (LIVN) Announces Thad Huston As Chief Financial Officer 5/16/2017 9:23:55 AM
LivaNova (LIVN) Announces New Data Reaffirming Value Of Perceval For Aortic Valve Replacement In Aortic Stenosis Patients 5/4/2017 7:48:14 AM
123
//-->